Cargando…
The determination of the effect(s) of solute carrier family 22-member 2 (SLC22A2) haplotype variants on drug binding via molecular dynamic simulation systems
Single nucleotide polymorphisms detected in the solute carrier member family-22 has been shown to result in a variable response in the treatment of type 2 diabetes mellitus with Metformin. This study predicted a three-dimensional protein structure for the SLC22A2 protein sequence using AlphaFold 2 a...
Autores principales: | Abrahams-October, Zainonesa, Johnson, Rabia, Benjeddou, Mongi, Cloete, Ruben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547889/ https://www.ncbi.nlm.nih.gov/pubmed/36209293 http://dx.doi.org/10.1038/s41598-022-21291-4 |
Ejemplares similares
-
Socio-demographic and modifiable risk factors of diabetes and hypertension among resource constrained patients from rural areas in Mdantsane Township in South Africa
por: Xhakaza, Lettilia, et al.
Publicado: (2020) -
Genetic polymorphisms and haplotypes of the organic cation transporter 1 gene (SLC22A1) in the Xhosa population of South Africa
por: Jacobs, Clifford, et al.
Publicado: (2014) -
Genetic preservation of SLC22A3 in the Admixed and Xhosa populations living in the Western Cape
por: Pearce, Brendon, et al.
Publicado: (2023) -
Maternal Primary Carnitine Deficiency and a Novel Solute Carrier
Family 22 Member 5 (SLC22A5) Mutation
por: Jakoby, Michael, et al.
Publicado: (2021) -
Genetic Association of Solute Carrier Transporter Gene Variants with Metformin Response
por: Abrahams-October, Z, et al.
Publicado: (2021)